Mysterious Child Fevers Of Unknown Origin: Could Surgery Be A Cure? A child spikes a high fever, sometimes as high as 104 or 105 degrees, and sometimes causing seizures. She's rushed to the emergency room, the hospital runs test after test, specialists are brought in, but no explanation is found.Many families though no one knows how many go through this cyclical nightmare.
Source: www.medicalnewstoday.comA Vision For Infrastructure In The 21st Century On Thursday, April 10, the National Science Foundation (NSF) and Popular Mechanics will co-host a webcast conference to address challenges and solutions driving the future of infrastructure in the United States.
Source: www.medicalnewstoday.comVIRxSYS Presents Data On HIV Vaccine At Keystone HIV Vaccine Symposia VIRxSYS Corporation will present initial scientific data for VRX1023 at the Keystone Symposia Conference in Banff, Alberta. VRX1023 is part of a new vaccine approach -- using HIV-based lentivector as vector boost. VRX1023, an HIV antigen expressing lentiviral vector, has produced positive results in mice and in preliminary non-human primate studies.
Source: www.medicalnewstoday.comStudy Finds Repeated Episodes Of Stent Thrombosis Common When a clot develops inside a coronary stent, it can block blood flow to the heart, potentially causing a heart attack or even death. A single incident of stent thrombosis is bad enough, but a new study suggests that one in six patients can expect to experience at least one repeat episode.
Source: www.medicalnewstoday.comStudy Finds PCI Safe, Effective Despite Off Site Cardiac Surgery Percutaneous coronary intervention (PCI) can be performed safely and successfully in medical centers without on-site cardiac surgical back-up, provided programs are well-organized, highly skilled and committed to quality.
Source: www.medicalnewstoday.comStudy Results Show Investigational Drug, Prasugrel, Cuts Risk Of Stent-Related Clots By More Than Half Versus Clopidogrel The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix(R)) plus aspirin (1.13 percent vs. 2.
Source: www.medicalnewstoday.com
# posted by Network @ 10:00 AM
